MARKET

OXFD

OXFD

Oxford Immunotec
NASDAQ

Real-time Quotes | Nasdaq Last Sale

16.72
-0.32
-1.88%
Opening 12:37 11/12 EST
OPEN
17.04
PREV CLOSE
17.04
HIGH
17.04
LOW
16.65
VOLUME
84.85K
TURNOVER
--
52 WEEK HIGH
18.60
52 WEEK LOW
11.88
MARKET CAP
442.19M
P/E (TTM)
14.20
1D
5D
1M
3M
1Y
5Y

Buy or sell shares of OXFD and other stocks commission-free!

Open a Webull account and fund it to get a free stock

Analyst Rating

Based on 5 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

EPS

OXFD News

  • Edited Transcript of OXFD earnings conference call or presentation 5-Nov-19 1:00pm GMT
  • Thomson Reuters StreetEvents.2d ago
  • Oxford Immunotec Global PLC (OXFD) CEO Peter Wrighton-Smith on Q3 2019 Results - Earnings Call Transcript
  • Seeking Alpha - Transcript.3d ago
  • Here is What Hedge Funds Think About Oxford Immunotec Global (OXFD)
  • Insider Monkey.5d ago
  • Oxford Immunotec Global PLC 2019 Q3 - Results - Earnings Call Presentation
  • Seeking Alpha - Article.11/05 15:30

More

Industry

Advanced Medical Equipment & Technology
+0.73%
Healthcare Equipment & Supplies
+0.69%

Hot Stocks

Name
Price
%Change

About OXFD

Oxford Immunotec Global PLC,is a diagnostics company. It is focused on developing and commercializing tests for under-served immune-regulated conditions. Its product lines and development activities principally focus on four areas: infectious diseases, transplantation, autoimmune and inflammatory disease and immune-oncology. It offers a range of assays for tick-borne diseases, such as Lyme disease, obtained through the acquisitions of Imugen and Immunetics. Tick-borne disease is the collective name for diseases passed to humans through the bite of an infected tick. Its diagnostic tests for tick-borne infections include multiple laboratory developed tests (LDTs). Its tick-borne disease tests utilize molecular methods (such as polymerase chain reaction) and techniques to prosecute the immune system. It has a series of assays for use in blood screening, building upon its expertise in tick-borne disease.
More

Webull offers Oxford Immunotec Global PLC (OXFD) stock price, real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, stock news, and many more online research tools to help you make informed decisions.